Trial Profile
A Prospective, Randomised, Multicenter Phase II/III Clinical Trial to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT Versus Placebo
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 25 Mar 2013
Price :
$35
*
At a glance
- Drugs AMT 2003 (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 06 Oct 2006 New trial record.